A PHASE IV MULTICENTER, OPEN-LABEL STUDY EVALUATING B CELL LEVELS IN INFANTS OF LACTATING WOMEN WITH CIS OR MS RECEIVING OCRELIZUMAB
Details
Age
Child to Adult
Type of Study
Outcomes Research
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Anna Shah, MD
Study ID
Protocol Number: 22-0387
More information available at ClinicalTrials.gov: NCT04998851
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers